is now

Please update your bookmarks and favorites.
You will be taken to the new site in a few seconds.

Pathology Laboratory Services

Miraca Life Sciences is now Inform Diagnostics! Serving more than 5,500 patients each day, Inform Diagnostics is a leading, academic-caliber anatomic pathology laboratory, providing diagnostic services in the fields of breast health, dermatology, gastroenterology, hematology and urology. Building on our experience with health IT, we also offer technology solutions and consulting services to assist clinicians and centers with MIPS and other reporting requirements.

Inform Diagnostics Research & Development Services utilize our expertise and resources as a premier anatomic pathology commercial laboratory. Inform Diagnostic’s difference is in our ability to draw upon the foundation of our commercial laboratory, to provide pathology, laboratory and data services.

We employ a talented team of leading pathologists, histologists, lab technicians, technology consultants, and other medical professionals — all driven to help provide the highest and most up-to-date levels of diagnostic quality, enhanced workflow and practice solutions possible. It’s part of our commitment: not only to scientific excellence, but to you.

Pathology Research & Publications

Our skilled team of field-specific clinical pathologists, consultants and experts work diligently to stay at the forefront of the ever-changing landscape of a pathology laboratory and health IT. As part of this diligence, we work closely with one another to provide the highest quality, academic-based research and information possible.

Recent News


January 8, 2018

Miraca Life Sciences Announces Company Name Change to Inform Diagnostics

IRVING, Texas, January 8, 2018 — Miraca Life Sciences announced today that it has changed its name to Inform Diagnostics effective immediately. The company was acquired in November by Avista Capital Partners from previous owner Miraca Holdings. The name Inform Diagnostics and new logo were chosen to highlight the company’s focus on providing pathology and diagnostic capabilities that together help […]

Continue reading


November 20, 2017

Avista Capital Partners Completes Acquisition of Miraca Life Sciences

IRVING, Texas and NEW YORK, Nov. 20, 2017 — Avista Capital Partners (“Avista”), a leading private equity firm, today announced the completion of its acquisition of Miraca Life Sciences (“MLS” or the “Company”) from Miraca Holdings Inc.

Continue reading the press release at the Avista website.

Continue reading


The dermatopathologists are very easy to work with and will pick up the phone to discuss pathology if there are any questions.
— Susan Seidel, RN,
Office Manager,Stone Oak Dermatology, San Antonio, Texas


READ MORE

Featured Subspecialty Expert


Cristian I. Robiou, MD

Director of Medical Quality Assurance

more